CTOs on the Move

The Hope Heart Institute

www.hopeheart.org

 
The Hope Heart Institute is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.hopeheart.org
  • 1380 112th Ave NE Ste 200
    Bellevue, WA USA 98004
  • Phone: 206.903.2001

Executives

Name Title Contact Details

Similar Companies

FORME

At Forme, we specialize in designing and manufacturing innovative and high-quality health and wellness products. Our extensive range includes sports nutrition, weight loss supplements, and vitamins to support overall wellbeing. We are dedicated to prov...

Den-Mat Holdings, LLC.

Den-Mat Corp has also developed revolutionary LUMINEERS BY CERINATE, the first porcelain laminates that are contact lens-thin and strong, eliminating the need for the shaving and grinding down of sensitive tooth structure.

ClaimPay

Claimpay is a healthcare billing company that combines smart technology with billing expertise to manage a practices entire revenue process.

Avantec Software

Avantec Software is a Redmond, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kite Pharma

Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.